{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:54:32Z","timestamp":1779911672369,"version":"3.53.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":356,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":356,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiaxing Hengjie Biopharmaceutical Co. Ltd. , China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. exp. orthop."],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Knee osteoarthritis (OA) is the most common form of clinical arthritis in middle\u2010aged and older individuals. Undenatured or native type II (TII) collagen derived from the chicken sternum has a good therapeutic effect on relieving severe pain of OA. Hence, the present study aimed to investigate the efficacy and safety of TII collagen (Native CT\u2010II\u00ae) in individuals with knee OA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a 12\u2010week randomised, double\u2010blind, placebo\u2010controlled, parallel\u2010group study on 101 participants aged 40\u201365 years with knee OA. The participants were randomised to receive either TII collagen, glucosamine hydrochloride\u2009+\u2009chondroitin sulfate (G\u2009+\u2009C) or a placebo. The primary outcome was an improvement in the joint health of the participants assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) compared to G\u2009+\u2009C and placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the placebo group (\n                      <jats:italic>n\u2009<\/jats:italic>\n                      =\u200927), the TII collagen group (\n                      <jats:italic>n\u2009<\/jats:italic>\n                      =\u200929) and G\u2009+\u2009C group (\n                      <jats:italic>n\u2009<\/jats:italic>\n                      =\u200929) significantly improved the overall joint health measured by the change in WOMAC total score (week 12: TII collagen\u2009=\u2009\u201032.47\u2009\u00b1\u200919.51 and G\u2009+\u2009C\u2009=\u2009\u201033.74\u2009\u00b1\u200924.64 vs. placebo\u2009=\u2009\u201013.84\u2009\u00b1\u200917.61; p\u2009&lt;\u20090.05) and relieved knee joint pain (week 12: TII collagen\u2009=\u2009\u20105.69\u2009\u00b1\u20093.66 and G\u2009+\u2009C\u2009=\u2009\u20106.03\u2009\u00b1\u20094.72 vs. placebo\u2009=\u2009\u20102.71\u2009\u00b1\u20093.95; p\u2009&lt;\u20090.05). The statistically significant effect was observed as early as 4 weeks after the investigational product administration. Additionally, the TII collagen was more effective in improving the quality of life than the G\u2009+\u2009C.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TII collagen not only has a significantly better effect and high safety profile for OA but also improves the quality of life of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>Level 1 \u2013 Randomized Controlled Trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04470336\">NCT04470336<\/jats:ext-link>\n                      ; First submitted date: July 08, 2020; First posted date: July 14, 2020.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40634-022-00559-8","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:02:45Z","timestamp":1671764565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of native type II collagen in modulating knee osteoarthritis symptoms: a randomised, double\u2010blind, placebo\u2010controlled trial"],"prefix":"10.1002","volume":"9","author":[{"given":"Cheng","family":"Luo","sequence":"first","affiliation":[{"name":"Research and Development Jiaxing Hengjie Biopharmaceutical Co. Ltd No.20 Tongyi Road, Xinfeng Industrial Park 314005 Jiaxing Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weike","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Zhejiang University of Technology 310023 Hangzhou Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Zhejiang University of Technology 310023 Hangzhou Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-5929","authenticated-orcid":false,"given":"Shalini","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Clinical Development Vedic Lifesciences Pvt. Ltd 118, Morya House, Off New Link Road, Andheri (West) 400053 Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"e_1_2_12_2_2","volume-title":"StatPearls","author":"Hsu H","year":"2022"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100587"},{"key":"e_1_2_12_4_2","unstructured":"MarketsandMarkets(2020) Osteoarthritis Therapeutics Market \u2010 Global Forecast to 2025.https:\/\/www.marketsandmarkets.com\/Market\u2010Reports\/osteoarthritis\u2010therapeutics\u2010market\u2010209565994.html?gclid=CjwKCAjw2bmLBhBREiwAZ6ugo5Mqec4ajgZ8UxP4N6eR59eIIuOockof56d8Qu1ivJEQxmLS79_PVxoCKksQAvD_BwE. Accessed October 19 2021."},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/2309499018808669"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.33545\/26631067.2021.v3.i1a.56"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.22271\/ortho.2021.v7.i2k.2713"},{"key":"e_1_2_12_8_2","first-page":"1396","volume-title":"Nutraceuticals \u2010 efficacy, safety and toxicity","author":"Gupta RC","year":"2021"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar3657"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/230949900901700116"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.10.013"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/969012"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42358\u2010018\u20100041\u20109"},{"issue":"5","key":"e_1_2_12_14_2","first-page":"469","article-title":"Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis","volume":"48","author":"Qiu GX","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6.312"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12937\u2010016\u20100130\u20108"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.617789"},{"key":"e_1_2_12_18_2","first-page":"15","article-title":"Improving effect of Native CT\u2010II on the monoiodoacetic acid\u2010Induced Osteoarthritis in rats","volume":"29","author":"Wu TT","year":"2020","journal-title":"China Pharmaceuticals"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1550\u20102783\u201010\u201048"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000138087.47382.6d"},{"issue":"6","key":"e_1_2_12_21_2","first-page":"1365","article-title":"Randomized double\u2010blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis","volume":"27","author":"Chopra A","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136\u2010018\u20101929\u2010x"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.37.1.45"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1999.0308"},{"key":"e_1_2_12_25_2","first-page":"16","volume":"21","author":"Lespasio MJ","year":"2017","journal-title":"Knee Osteoarthritis: A Primer Perm J"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324607"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891\u2010019\u20102895\u20103"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.6.S291"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2018.07.015"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102013\u2010203954"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102014\u2010206792"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067\u2010014\u20102757\u20101"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports\u20102016\u2010097333"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key005"}],"container-title":["Journal of Experimental Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40634-022-00559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40634-022-00559-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40634-022-00559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/esskajournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1186\/s40634-022-00559-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:14:12Z","timestamp":1760642052000},"score":1,"resource":{"primary":{"URL":"https:\/\/esskajournals.onlinelibrary.wiley.com\/doi\/10.1186\/s40634-022-00559-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1186\/s40634-022-00559-8"],"URL":"https:\/\/doi.org\/10.1186\/s40634-022-00559-8","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1080857\/v1","asserted-by":"object"}]},"ISSN":["2197-1153","2197-1153"],"issn-type":[{"value":"2197-1153","type":"print"},{"value":"2197-1153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki, ICH-GCP, and Ethical guidelines for biomedical research on human participants 2006, issued by the Indian Council of Medical Research, India. The ACEAS-Independent Ethics Committee, Ahmedabad, India (CDSCO Reg. No. ECR\/281\/Indt\/GJ\/2017\/RR-21; dated February 04, 2021, and OHRP & DHHS IRB No. IRB00011046; IORG No.: IORG0009271; dated May 09, 2022) approved and monitored the study (Protocol approval ID: JHB\/190702\/NATIVECTII\/OA; dated March 21, 2020) for Mumbai site and the Shubham Sadbhawana Hospital Ethics Committee, Varanasi (Reg. No.: ECR\/667\/lnst\/UP\/2014\/RR-20; dated December 30, 2020) approved and monitored the study at the Varanasi site (Protocol approval ID: JHB\/190702\/NATIVECTII\/OA; dated October 08, 2020). All the participants provided written informed consent before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CL is affiliated with Jiaxing Hengjie Biopharmaceutical Co. Ltd., Zhejiang, China. The other authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"123"}}